Inventor · disambiguated record
Anderson Joseph Ryan
Also filed as: RYAN ANDERSON J · RYAN ANDERSON JOSEPH
0 granted patents·15 pending applications·0 citations·filing 2003–2011
Top patents by PatentIndex Score
15 records- 0151US2010215773A1Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular PermeabilityASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 0247US2010130520A1Combination therapyWEDGE STEPHEN ROBERT·Filed 2009·Application pending·0 cites
- 0345US2006167027A1Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeabilityWEDGE STEPHEN R·Filed 2004·Application pending·0 cites
- 0440US2012263802A1Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular PermeabilityWEDGE STEPHEN ROBERT·Filed 2011·Application pending·0 cites
- 0539US2011086870A1Combination TherapyASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 0637US2006142316A1Combination therapyWEDGE STEPHEN R·Filed 2004·Application pending·0 cites
- 0736US2012252826A1Combination TherapyWEDGE STEPHEN ROBERT·Filed 2011·Application pending·0 cites
- 0834US2008269261A1Combination of Zd6474 and PemetrexedRYAN ANDERSON JOSEPH·Filed 2006·Application pending·0 cites
- 0930US2011212978A1Combination of ZD6474 and PemetrexedASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 1027US2010092466A1Combination of zd6474 and bevacizumab for cancer therapyRYAN ANDERSON JOSEPH·Filed 2007·Application pending·0 cites
- 1126US2012107305A1Combination TherapyRYAN ANDERSON JOSEPH·Filed 2011·Application pending·0 cites
- 1223US2005215530A1Combination therapy for the treatment of cancerRYAN ANDERSON J·Filed 2003·Application pending·0 cites
- 1322US2011028498A1Method for evaluating patients for treatment with drugs targeting ret receptor tyrosine kinaseRYAN ANDERSON JOSEPH·Filed 2007·Application pending·0 cites
- 1418US2006142239A1Potassium or sodium salt of (-)-2-(4-hydroxyphenyl)ethyl!-thio-3-'4-{4-'(methzlsulfonzl)oxy !phenoxy}phenyl!propanoic acid and their use in medicineRYAN ANDERSON J·Filed 2004·Application pending·0 cites
- 1513US2008032954A1Vascular Damaging Agents for Administration as an Intravenous InfusionRYAN ANDERSON J·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anderson Joseph Ryan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →